Tanner Pharma Group Announces New Managing Director Of UK Operation

CHARLOTTE, N.C.--(BUSINESS WIRE)--Tanner Pharma Group is pleased to announce the hiring of Jonathan Bracey as Managing Director – UK, effective 1 December, 2015.

Mr. Bracey brings two decades of management experience, making him an optimal candidate in leading the recently established UK/EU operations based in London. Prior to joining Tanner Pharma Group, Mr. Bracey led various operations in Big Pharma, Specialty Pharma, Generics and most recently consultancy within the pharmaceutical industry. Within these organizations, he worked in general management, operations, sales, procurement, and supply chain roles with UK, EU, MENA, and Global reach. Mr. Bracey also served in HMS as a logistics officer.

Suggested Articles

Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.